Moderna’s Coronavirus Vaccine Shows Early Progress

Greetings, QuickTake readers! In this edition: Reopening may come too late for Italian retailers, FBI blasts Apple over encrypted gunman's iPhones and robonauts are space exploration's next frontier.

The first Covid-19 vaccine to be tested in humans appears safe and able to generate coronavirus-killing antibodies in test subjects, Moderna said Monday. The findings are just a sample from its phase one clinical trial in which eight volunteers who were given two doses of the vaccine in March developed antibodies on par with recovered virus patients.